STOCK TITAN
  1. Home
  2. Sec-filings
  3. FMFC
  4. [6-K] Kandal M Venture Ltd Current Report (Foreign Issuer)

Kandal M Venture (NASDAQ: FMFC) wins more time to fix $1 bid-price shortfall

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Kandal M Venture Limited reports that Nasdaq has granted it an additional 180-day period, until December 21, 2026, to regain compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1 per share for continued listing.

The company previously had until June 22, 2026 to cure the deficiency. If it does not meet the $1 minimum bid price by the new deadline, Nasdaq staff may move to delist its securities, though the company would have the right to appeal to a Hearings Panel. Kandal M Venture Limited states it is evaluating options and intends to regain compliance, but there is no assurance it will do so.

Positive

  • None.

Negative

  • Heightened delisting risk from Nasdaq: Kandal M Venture Limited has a continued bid-price deficiency under Nasdaq Listing Rule 5550(a)(2) and must raise its share price to at least $1 by December 21, 2026 or face potential delisting, with no assurance it can regain compliance.

Insights

Nasdaq granted more time to fix Kandal M Venture’s bid-price deficiency, but delisting risk remains if it cannot lift its share price.

Kandal M Venture Limited has received a second 180-day grace period from Nasdaq, moving its minimum bid price compliance deadline to December 21, 2026. Listing Rule 5550(a)(2) requires shares to trade at or above $1 to remain on the Capital Market.

If the company fails to restore its bid price to at least $1 by the new deadline, Nasdaq staff may notify it of delisting, although a Hearings Panel appeal is available. The company notes it is evaluating options and intends to regain compliance but explicitly acknowledges there is no assurance of success.

Nasdaq minimum bid price $1 per share Required under Nasdaq Listing Rule 5550(a)(2)
Initial compliance period 180 calendar days From December 22, 2025 to June 22, 2026
Extended compliance deadline December 21, 2026 Additional 180-day period to regain $1 bid price
Review period for deficiency Nov 6–Dec 19, 2025 Period when closing bid price was below $1
Nasdaq Listing Rule 5550(a)(2) regulatory
"the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2)"
minimum bid price financial
"to maintain a minimum bid price of $1 per share"
The minimum bid price is the lowest share price that a market, regulator, or specific offering will accept for a trade, listing, or auction—think of it as a reserve or floor that a stock must meet to qualify for certain actions. It matters to investors because falling below that floor can limit trading options, trigger compliance measures or delisting risks, and affect liquidity and the perceived value of a holding, much like a reserve price in an auction sets the baseline for a sale.
continued listing requirement regulatory
"the Company no longer meets the continued listing requirement of Nasdaq"
Rules a stock exchange sets that a publicly traded company must follow to keep its shares listed, such as minimum share price, market value, shareholder equity, and timely financial reporting. These rules matter to investors because failing them can lead to removal from the exchange, which can make shares harder to buy or sell and often lowers their value — like a club with membership requirements where losing eligibility restricts access and signals trouble.
Hearings Panel regulatory
"the Company may appeal Nasdaq Staff’s determination to a Hearings Panel"
A hearings panel is a small group of officials or experts who hold formal sessions to review evidence, question parties, and make decisions about regulatory compliance, discipline, or approvals. Think of it like a review board or courtroom for business and market issues: its findings can lead to fines, changes in a company’s permissions, or even delisting. Investors pay attention because the panel’s rulings can directly affect a company’s operations, reputation and share price.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 6-K: How Foreign Companies Report to the SEC →

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 6-K

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of June 2026

 

Commission File Number: 001-42715

 

 

 

Kandal M Venture Limited

(Registrant’s Name)

 

 

 

Padachi Village, Prek Ho Commune, Takhmao Town, Kandal Province, Kingdom of Cambodia
+855-23425205

(Address of Principal Executive Offices)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒          Form 40-F ☐

 

 

 

  

 

 

Nasdaq Minimum Bid Price Deficiency Letter

 

As previously disclosed, on December 22, 2025, Kandal M Venture Limited (the “Company”) received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that based on the closing bid price of the Company for the period from November 6, 2025 to December 19, 2025, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share.  Nasdaq has provided the Company with an 180 calendar days compliance period, or until June 22, 2026, in which to regain compliance with Nasdaq continued listing requirement.

 

On June 23, 2026, the Company received a letter from Nasdaq, indicating that the Company is granted an additional 180 calendar days, until December 21, 2026, to regain compliance with the minimum bid price requirement of $1 per share, as stipulated by Nasdaq Listing Rule 5550(a)(2). If compliance cannot be demonstrated by December 21, 2026, Nasdaq Staff will provide written notification that the Company’s securities will be delisted. At that time, the Company may appeal Nasdaq Staff’s determination to a Hearings Panel.

 

The Company is currently evaluating options to regain compliance and intends to timely regain compliance with Nasdaq’s continued listing requirement. While we aim to comply with Rule 5550(a)(2), there can be no assurance to regain compliance with that rule or in compliance with other Nasdaq continued listing requirement.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Kandal M Venture Limited
   
Date: June 24, 2026 By: /s/ Duncan Miao
  Name:  Duncan Miao
  Title: Chairman of the Board and Director

 

2

 

Source: View Original Filing on SEC EDGAR

FAQ

What Nasdaq issue does Kandal M Venture Limited disclose in this 6-K?

Kandal M Venture Limited discloses a continued Nasdaq minimum bid price deficiency. Its shares have traded below the required $1 per share threshold under Listing Rule 5550(a)(2), putting its Nasdaq Capital Market listing at risk if compliance is not restored.

What is the new Nasdaq compliance deadline for Kandal M Venture Limited?

Nasdaq granted Kandal M Venture Limited an additional 180 days, extending the compliance deadline to December 21, 2026. By that date, the company must demonstrate a closing bid price of at least $1 per share to satisfy Listing Rule 5550(a)(2).

What happens if Kandal M Venture Limited fails to meet Nasdaq’s $1 bid requirement?

If Kandal M Venture Limited cannot demonstrate compliance with the $1 minimum bid price requirement by December 21, 2026, Nasdaq staff may provide written notice that its securities will be delisted, although the company could then appeal to a Nasdaq Hearings Panel.

What actions is Kandal M Venture Limited taking to regain Nasdaq compliance?

Kandal M Venture Limited states it is currently evaluating options to regain compliance with Nasdaq’s continued listing requirements and intends to do so in a timely manner. However, it cautions there can be no assurance that it will successfully restore compliance.

Which Nasdaq rule applies to Kandal M Venture Limited’s bid-price deficiency?

The deficiency relates to Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1 per share for continued listing on the Nasdaq Capital Market. The company’s closing bid price fell below this level over a specified review period.